|
Market Cap (17-May) $40,671,720 (1,053rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 400,697 |
Shortsold (10-Dec) 1,128,575 (0.62%) (255th) |
|
52w High $0.345 |
52w Low $0.140 |
P/E - |
EPS -0.05 |
CYP released this announcement to the ASX on 21 October 2022, 16:51. The announcement is not marked as price sensitive, and is 84 page(s) in length and 6.5MB in size.
You can view all announcements from CYP and see how they appear on a price chart on the announcements page.
At the date of this announcement, CYP was 0.003% short sold according to ASIC data. It was ranked the 613th most shorted stock on the ASX. It is now ranked as the 255th most shorted stock on the ASX with 0.624% of total shares short sold as of the latest reported data (10 December 2024).
| Other Recent Announcements from CYP | |
|---|---|
| Notification regarding unquoted securities - CYP | 30 June 2023, 13:10 |
| Proposed issue of securities - CYP | 30 June 2023, 9:44 |
| Cynata announces CEO succession and Board changes | 30 June 2023, 9:13 |
| Annual Report to Shareholders | 21 October 2022, 16:51 |
| Letter to Shareholders, Notice of AGM & Proxy Form | 21 October 2022, 16:46 |
| Notice of Allowance for Australia & Canada Cymerus Patents | 17 October 2022, 9:28 |
| Successful Completion of Planned DSMB Review of DFU Trial | 12 October 2022, 9:26 |
You must be logged in to post a reply.
Cynata Therapeutics 